The Crescent™* catheter is the first FDA-cleared, jugular dual lumen long-term ECMO catheter. It allows for more accurate placement with just one cannulation site, delivers enhanced flow dynamics, and helps maintain optimal flow† once placed.Product Details
We understand the value of VV ECMO therapy, and now you have the option to provide your pediatric patients with the same game-changing flow† you expect from the Crescent™* catheter name. The Crescent™* RA jugular dual lumen catheter offers a right atrial design and includes both an introducer for a percutaneous technique and a blunt-tip obturator for a surgical cut-down technique.Product Details
™Third-party brands are trademarks of their respective owners.
Data on file at MC3. These tests may not be indicative of clinical performance.
Important Safety Information
Care and caution should be taken to avoid damage to vessels and cardiac tissue during cannulation or other cardiac surgery procedures. For a listing of indications, contraindications, precautions, warnings, and potential adverse events, please refer to the Instructions for Use.
Crescent and Crescent RA: Only physicians with previous training and experience with venous catheterization and extracorporeal life support should use this device.
Caution: Federal law (USA) restricts this device to sale by or on the order of a physician.
Crescent™* and Crescent RA jugular dual lumen catheters are manufactured by MC3, Inc. and exclusively distributed by Medtronic.